化学 - 特种化学品

Search documents
Celanese (CE) Up 8.4% Since Last Earnings Report: Can It Continue?
ZACKS· 2025-09-10 16:30
Core Viewpoint - Celanese's recent earnings report shows mixed results, with a notable decline in adjusted earnings and revenues, while the stock has outperformed the S&P 500 in the past month [1][3][4]. Financial Performance - Celanese reported Q2 2025 earnings from continuing operations of $1.90 per share, up from $1.42 in the prior-year quarter, but adjusted earnings fell 39.5% to $1.44 per share from $2.38 a year ago [3]. - Revenues for the quarter were approximately $2.53 billion, a decrease of about 4.5% year over year, but exceeded the Zacks Consensus Estimate of $2.50 billion [4]. - The Engineered Materials unit generated net sales of around $1.44 billion, down 1.7% year over year, while the Acetyl Chain segment posted net sales of approximately $1.12 billion, down 7.2% year over year [5][6]. - Cash and cash equivalents at the end of the quarter were roughly $1.17 billion, up 23.3% sequentially, while long-term debt increased by 2.5% to approximately $12.69 billion [7]. Outlook - The company anticipates a softer demand environment for the second half of the year, which may offset the benefits of cost reduction initiatives [8]. - Adjusted earnings per share for Q3 are projected to be in the range of $1.10 to $1.40, with expectations to generate $700 million to $800 million in free cash flow for 2025 [8]. - There has been a downward trend in estimates, with a consensus estimate shift of -27.14% in the past month [9][12]. Industry Context - Celanese operates within the Zacks Chemical - Specialty industry, where PPG Industries, a peer, reported revenues of $4.2 billion for the last quarter, reflecting a year-over-year decline of 12.5% [13]. - PPG Industries is expected to post earnings of $2.12 per share for the current quarter, indicating a slight year-over-year change of -0.5% [14].
Green Plains Renewable Energy (GPRE) Reports Q2 Loss, Misses Revenue Estimates
ZACKS· 2025-08-11 13:06
Core Viewpoint - Green Plains Renewable Energy (GPRE) reported a quarterly loss of $0.41 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.28, and compared to a loss of $0.38 per share a year ago [1][2]. Financial Performance - The company experienced an earnings surprise of -46.43% for the quarter, having previously expected a loss of $0.51 per share but reporting a loss of $0.88, resulting in a surprise of -72.55% [2]. - Green Plains posted revenues of $552.83 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 6.66%, and down from $618.83 million in the same quarter last year [3]. - Over the last four quarters, the company has only surpassed consensus EPS estimates once and has topped consensus revenue estimates just once [2][3]. Stock Performance - Green Plains shares have declined approximately 21.9% since the beginning of the year, contrasting with the S&P 500's gain of 8.6% [4]. - The current Zacks Rank for the stock is 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [7]. Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.03 on revenues of $599.3 million, and for the current fiscal year, it is -$1.33 on revenues of $2.4 billion [8]. - The estimate revisions trend for Green Plains was mixed ahead of the earnings release, and future revisions may change following the recent report [7]. Industry Context - The Chemical - Specialty industry, to which Green Plains belongs, is currently ranked in the bottom 35% of over 250 Zacks industries, indicating potential challenges for stock performance [9].
Balchem (BCPC) Surpasses Q2 Earnings and Revenue Estimates (Revised)
ZACKS· 2025-08-01 20:16
Company Performance - Balchem (BCPC) reported quarterly earnings of $1.27 per share, exceeding the Zacks Consensus Estimate of $1.25 per share, and up from $0.98 per share a year ago, representing an earnings surprise of +1.60% [1] - The company posted revenues of $255.47 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.41%, compared to $234.08 million in the same quarter last year [2] - Over the last four quarters, Balchem has surpassed consensus EPS estimates just once and topped consensus revenue estimates two times [2] Market Outlook - Balchem shares have declined approximately 6.7% since the beginning of the year, while the S&P 500 has gained 8.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $1.36 on revenues of $261.58 million, and for the current fiscal year, it is $5.15 on revenues of $1.03 billion [7] Industry Context - The Chemical - Specialty industry, to which Balchem belongs, is currently ranked in the bottom 33% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The current status of estimate revisions for Balchem translates into a Zacks Rank 3 (Hold), suggesting the shares are expected to perform in line with the market in the near future [6]
Blachem (BCPC) Surpasses Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-31 13:16
Company Performance - Blachem (BCPC) reported quarterly earnings of $1.27 per share, exceeding the Zacks Consensus Estimate of $1.25 per share, and up from $0.98 per share a year ago, representing an earnings surprise of +1.60% [1] - The company posted revenues of $255.47 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.41%, compared to year-ago revenues of $234.08 million [2] - Over the last four quarters, Blachem has surpassed consensus EPS estimates just once and topped consensus revenue estimates two times [2] Stock Outlook - Blachem shares have declined approximately 6.7% since the beginning of the year, while the S&P 500 has gained 8.2% [3] - The current consensus EPS estimate for the upcoming quarter is $1.36 on revenues of $261.58 million, and for the current fiscal year, it is $5.15 on revenues of $1.03 billion [7] Industry Context - The Chemical - Specialty industry, to which Blachem belongs, is currently ranked in the bottom 33% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor sentiment [5]
Ecolab (ECL) Misses Q2 Earnings Estimates
ZACKS· 2025-07-29 14:10
Ecolab (ECL) came out with quarterly earnings of $1.89 per share, missing the Zacks Consensus Estimate of $1.9 per share. This compares to earnings of $1.68 per share a year ago. These figures are adjusted for non- recurring items. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have chan ...
Orion (OEC) Lags Q1 Earnings and Revenue Estimates
ZACKS· 2025-05-08 00:55
Financial Performance - Orion reported quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.53 per share, and down from $0.52 per share a year ago, representing an earnings surprise of -58.49% [1] - The company posted revenues of $477.7 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1.69%, and down from $502.9 million year-over-year [2] - Over the last four quarters, Orion has surpassed consensus EPS estimates only once and has not beaten consensus revenue estimates during the same period [2] Stock Performance - Orion shares have declined approximately 27.4% since the beginning of the year, compared to a decline of -4.7% for the S&P 500 [3] - The current Zacks Rank for Orion is 4 (Sell), indicating expectations for the stock to underperform the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.43 on revenues of $477.53 million, and for the current fiscal year, it is $1.60 on revenues of $1.86 billion [7] - The trend for estimate revisions ahead of the earnings release was unfavorable, which may impact future stock performance [6] Industry Context - The Chemical - Specialty industry, to which Orion belongs, is currently ranked in the bottom 44% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Another company in the same industry, CSW Industrials, is expected to report quarterly earnings of $2.23 per share, reflecting a year-over-year change of +9.3% [9]